GTCBIO ANNOUNCES ITS 4th ANNUAL NEURODEGENERATIVE DISEASES DRUG DISCOVERY CONFERENCE ON OCTOBER 9-10, 2008 IN PHILADELPHIA, PA
GTCbio just announced the scheduling of its 4th annual Neurodegenerative Diseases Drug Discovery Conference on October 9-10, 2008 in Philadelphia, PA.

/Biotechnology News Articles/ - MONROVIA, CA, August 09, 2008 - GTCbio just announced the scheduling of its 4th annual Neurodegenerative Diseases Drug Discovery Conference on October 9-10, 2008 in Philadelphia, PA.

Neurodegenerative diseases continue to play an enormous role in the growing public health problem, disrupting the quality of life of millions of people and costing society billions of dollars annually.

Nonetheless, in the last few years, there has been great progress in the development of novel therapeutic approaches to treat Alzheimer's, Parkinson's, Huntington's, Multiple Sclerosis, Stroke and various other neurodegenerative diseases. There have also been significant developments in our understanding of the genetics, the molecular mechanisms and signaling pathways contributing to neuronal dysfunction, neurotoxicity and pathology.

At the Neurodegenerative Diseases Drug Discovery forum, leading scientists and experts will discuss these latest breakthroughs, new drug targets, new models, the development of new biomarkers, imaging modalities, improved clinical trial designs and several other novel developments and therapeutics to combat neurodegenerative conditions.

Keynote presenters include Eric Karran, Chief Scientific Officer of the Neurodegenerative Diseases Drug Hunting Team at Eli Lilly & Company and William Z. Potter, Vice President of Translational Neuroscience at
Merck & Co.

For more information on attending, presenting a poster, or sponsoring, please visit http://gtcbio.com/conferenceDetails.aspx?id=133.

Press Release Contact Information:

Rania Hafez
GTCbio
Marketing Director
434 W. Foothill Blvd.
Monrovia, CA
USA 91106
Voice: 626-256-6405
Fax: 626-256-6460
Website: Visit Our Website